17-65538235-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_004655.4(AXIN2):​c.1168A>G​(p.Ser390Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,614,190 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S390C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00073 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 2 hom. )

Consequence

AXIN2
NM_004655.4 missense

Scores

1
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:14

Conservation

PhyloP100: 2.50

Publications

8 publications found
Variant links:
Genes affected
AXIN2 (HGNC:904): (axin 2) The Axin-related protein, Axin2, presumably plays an important role in the regulation of the stability of beta-catenin in the Wnt signaling pathway, like its rodent homologs, mouse conductin/rat axil. In mouse, conductin organizes a multiprotein complex of APC (adenomatous polyposis of the colon), beta-catenin, glycogen synthase kinase 3-beta, and conductin, which leads to the degradation of beta-catenin. Apparently, the deregulation of beta-catenin is an important event in the genesis of a number of malignancies. The AXIN2 gene has been mapped to 17q23-q24, a region that shows frequent loss of heterozygosity in breast cancer, neuroblastoma, and other tumors. Mutations in this gene have been associated with colorectal cancer with defective mismatch repair. [provided by RefSeq, Jul 2008]
AXIN2 Gene-Disease associations (from GenCC):
  • oligodontia-cancer predisposition syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • tooth agenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • craniosynostosis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019017488).
BP6
Variant 17-65538235-T-C is Benign according to our data. Variant chr17-65538235-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 127934.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000729 (111/152328) while in subpopulation NFE AF = 0.00144 (98/68022). AF 95% confidence interval is 0.00121. There are 0 homozygotes in GnomAd4. There are 48 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 111 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004655.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN2
NM_004655.4
MANE Select
c.1168A>Gp.Ser390Gly
missense
Exon 5 of 11NP_004646.3Q9Y2T1
AXIN2
NM_001363813.1
c.1168A>Gp.Ser390Gly
missense
Exon 5 of 10NP_001350742.1E7ES00

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AXIN2
ENST00000307078.10
TSL:1 MANE Select
c.1168A>Gp.Ser390Gly
missense
Exon 5 of 11ENSP00000302625.5Q9Y2T1
AXIN2
ENST00000375702.5
TSL:1
c.1168A>Gp.Ser390Gly
missense
Exon 4 of 9ENSP00000364854.5E7ES00
ENSG00000266076
ENST00000577662.1
TSL:2
n.*1344A>G
non_coding_transcript_exon
Exon 7 of 7ENSP00000462418.1J3KSC3

Frequencies

GnomAD3 genomes
AF:
0.000729
AC:
111
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00144
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000734
AC:
184
AN:
250828
AF XY:
0.000693
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000324
Gnomad NFE exome
AF:
0.00142
Gnomad OTH exome
AF:
0.000817
GnomAD4 exome
AF:
0.00107
AC:
1559
AN:
1461862
Hom.:
2
Cov.:
38
AF XY:
0.00106
AC XY:
770
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33478
American (AMR)
AF:
0.000157
AC:
7
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000374
AC:
20
AN:
53406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00134
AC:
1491
AN:
1112008
Other (OTH)
AF:
0.000629
AC:
38
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
102
204
306
408
510
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000729
AC:
111
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.000644
AC XY:
48
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41592
American (AMR)
AF:
0.0000653
AC:
1
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00144
AC:
98
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
0
Bravo
AF:
0.000729
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00233
AC:
20
ExAC
AF:
0.000914
AC:
111
EpiCase
AF:
0.000927
EpiControl
AF:
0.00113

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
2
3
not specified (5)
-
-
3
Oligodontia-cancer predisposition syndrome (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
AXIN2-related disorder (1)
-
1
-
Colorectal cancer;C4082304:Oligodontia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.043
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.66
D
MetaRNN
Benign
0.019
T
MetaSVM
Uncertain
-0.24
T
PhyloP100
2.5
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.9
N
REVEL
Benign
0.29
Sift
Uncertain
0.022
D
Sift4G
Uncertain
0.033
D
Polyphen
0.17
B
Vest4
0.031
MVP
0.70
MPC
0.24
ClinPred
0.020
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.13
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139871607; hg19: chr17-63534353; COSMIC: COSV104596686; API